Marketing fat reduction treatments to male patients may seem difficult. Discover our marketing tips to effectively attract more male patients.
December 9, 2019
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Non-invasive fat reduction offers a significant growth opportunity in the medical aesthetics space. The fastest-growing area of cosmetic dermatology in 2018, as reported by Cutis, the global non-surgical fat reduction market value is forecast to surge to $2.5 billion by 2025, expanding at a compound annual growth rate of 15.9%. It’s no wonder the market is growing, though, with the waist being a top aesthetic concern for one-third of adults.
Much of this growth can be attributed to technological innovations that are introducing new aesthetic devices to the market that meet the needs of more male and female patients alike. As a medical aesthetics professional, you want to provide your clients with the safest and most effective treatments while maintaining a strong return on investment. However, choosing the right therapies to offer can be an intimidating task. Fortunately, we’re here to help with the decision-making process.
Here, we take a closer look at the market’s leading fat reduction devices, as well as important considerations for incorporating them into your practice.
Over the past decade, non-invasive fat reduction device technologies have been refined with cryolipolysis, radio frequency (RF), ultrasound, and laser being the top current modalities on the market. The different devices have varying mechanisms of action, but they all seek to damage or destroy fat cells, which are then eliminated by the body.
Cryolipolysis destroys fat cells by freezing them. In studies, the treatment is well tolerated with minimal discomfort and 73% patient satisfaction. Common side effects include bruising, swelling, tingling, and numbness. The treated area must be massaged after the procedure, which patients often describe as painful and adds to treatment time. Anecdotally, patients and practitioners report that pain and discomfort are not uncommon, and some patients have delayed onset pain requiring pain medication.
Several manufacturers offer RF-based fat reduction devices. Upon delivering radio frequency energy to fat cells, the impedance of the skin and adipose tissue creates heat that breaks down fat in the targeted treatment area. Depending on the device, skin tightening, collagen remodeling, and circumferential reduction may also be offered.
Some notable advantages of RF devices are that there are generally no consumable costs, the modality can address various other aesthetic issues, and applicators featuring a larger spot size can enable these devices to treat broader areas of the body. One notable drawback is that many RF-based fat reduction devices require a very hands-on treatment, requiring that the operator constantly move the applicator over the treatment area in order to deliver a safe and effective treatment.
Ultrasound fat reduction devices are based on two mechanisms: high-intensity focused ultrasound (HIFU) or focused pulsed ultrasound. Similar to RF, HIFU creates thermal energy to destroy fat cells, while focused pulsed ultrasound devices utilize acoustic energy to achieve the same result. While HIFU generally requires just one treatment for optimal results, some patients report discomfort with heat levels during treatment. In comparison, focused pulsed ultrasound devices generally require multiple treatments for optimal results but the experience is better tolerated among patients.
Laser modalities for non-invasive fat treatments are evolving rapidly and are the focus of much innovation.
The historical application of laser in fat reduction involves low-level laser, sometimes called cold laser. Using low levels of light, cold laser fat treatments disrupt the fat cells’ membranes, creating a temporary pore through which fat seeps out. Because the treatment utilizes six lasers, this method tends to offer more generalized body contouring. While the procedure is generally comfortable, it requires multiple treatment sessions with just a 47% “Worth It” rating on RealSelf.com. Further, patients must take a daily supplement, drink plenty of water, follow a low-fat diet, and eliminate caffeine and alcohol for optimal results, which places a lot of pressure on patients. It is also important to note that the procedure cannot target particular fat deposits, which requires providers to very clearly explain the procedure to patients.
Newer 1064 nm diode laser technology offers a significant advance. Non-invasive lipolysis using diode lasers at 1064 nm delivers wavelengths that penetrate the skin and target the adipose tissue layer, damaging fat cells via thermal energy. The treatment is safe for all skin types, takes no more than 30 minutes, is very comfortable, and does not require any downtime. A contact cooling system during treatment provides comfort for the patient and prevents damage to the surface of the skin. Patient satisfaction is more than 90%, and only mild side effects such as slight soreness and edema are seen. The abdomen and flanks can be treated with several studies showing a significant reduction in fat layer thickness.
Laser lipolysis devices have been available for a few years now, but innovation continues to improve the technology. One of the latest offerings, Venus Bliss™, is an advanced medical aesthetic device indicated for non-invasive lipolysis of the abdomen and flanks, resulting in fat reduction. It employs up to four diode laser applicators that have a large spot size, at 36 cm2each, allowing coverage for a larger treatment area. The applicator also provides uniform power distribution for homogenous heating throughout the treatment area. Balanced heat distribution supports consistent results and reduces hot spots that can cause pain or discomfort to the patient.
Looking for a more in-depth comparison of non-invasive fat reduction technologies on the market to help you decide which device is right for your clinic? Download our free report, The Skinny On Non-invasive Fat Reduction: How To Choose The Right Device To Meet The Rising Demand, using the button below for access to greater details and a helpful comparison chart.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More